Physician profile
Jerald Block
NPI 1598891319
$3,509.18
in general payments reported to CMS, 2019-2025
10 companies · $791 in 2025
The $791 reported for 2025 was more than what 78% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.29 · 2021: $43.55 · 2022: $303 · 2023: $80.29 · 2024: $2,258 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691 · Travel and Lodging: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.49 |
| Travel and Lodging | $1,437.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $2,582.02 | 2024-2025 | Neurostar Tms Therapy System |
| Alkermes, INC. | $375.93 | 2019-2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $219.79 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $114.46 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $80.29 | 2023 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $41.76 | 2019-2025 | Rexulti |
| Lundbeck LLC | $24.64 | 2025 | Rexulti |
| Abbvie INC. | $23.84 | 2025 | |
| Janssen Pharmaceuticals, INC | $23.83 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.62 | 2025 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerald Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.